VivoSim Labs, Inc. Expense Related to Distribution or Servicing and Underwriting Fees
VivoSim Labs, Inc. (VIVS) reported Expense Related to Distribution or Servicing and Underwriting Fees of $3.20 million for the 0-month period ending 2013-08-02, per its 10-K filed 2016-06-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFees · last filed 2016-06-09
- 2013-08-02: Expense Related to Distribution or Servicing and Underwriting Fees 0 month $3.20M.
| Period end | Expense Related to Distribution or Servicing and Underwriting Fees 0 month |
|---|---|
| 2013-08-02 | $3.20M 10-K · filed 2016-06-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |